CLINOVO LEADERSHIP TEAM
At Clinovo, leadership means more than titles — it’s a commitment to transforming how clinical research is executed. Our executive team brings decades of experience across life sciences, technology, and global operations. Together, they’re redefining the standard for clinical excellence — fostering innovation, empowering teams, and delivering faster, leaner, smarter solutions for sponsors worldwide.
Founder & Chairman
Vamsi is a seasoned global executive with over 25 years of experience in management consulting and entrepreneurship, spanning South Africa, the United States, and India.
CEO
Steve Matas is the CEO of Clinovo, with over 20 years in staffing and outsourcing experience, much of which has been within the field of clinical research.
VP of Business Development
Matt Gallant With 13+ years of expertise, Matt has a strong background in guiding clients through staff augmentation, workforce optimization, and outsourcing strategy.
Lead Clinical Advisor
Dawn McCollough With over 30 years of experience in the Pharmaceutical, Biotech, and Contract Research Organization (CRO) sectors, Dawn brings a proven track record of success in global clinical trial management across all phases and numerous therapeutic areas.
Chief Technology Officer
Nivedita (Neetha) is a technology executive and multiple- time founder with four successful startup exits. She has a deep technology background and vast experience ranging from Al, network technologies, cyber security to virtual reality.
At Clinovo, we deliver expert-led technology and workforce optimization solutions that accelerate clinical development with targeted precision. Eliminate barriers, achieve measurable ROI, and bring life-changing therapies to market faster.
Quick Links
Contact Us
Visit Us
Copyright 2025 Clinovo | All Rights Reserved
Founder & Chairman
Vamsi is a seasoned global executive with over 25 years of experience in management consulting and entrepreneurship, spanning South Africa, the United States, and India. His expertise lies in business administration, strategic growth, building high-performing teams, scaling businesses, and executing complex international M&A transactions. He has held key leadership roles at renowned organizations including Deloitte, Pfizer, Johnson & Johnson, and Merrill.
Vamsi is the Chairman of Clinovo, providing strategic oversight and driving strategic initiatives. He is also the Chairman of LAXAI, a small-molecule CRDMO company. In addition, he is a partner at Digilife, an early-stage venture fund that supports technology-driven startups addressing critical challenges in healthcare. Outside of his professional endeavors, Vamsi is an avid traveler and culinary enthusiast who enjoys immersing himself in diverse cultures. His passion for exploration reflects his dynamic and globally informed perspective in both business and life.
CEO
Steve Matas is the CEO of Clinovo, with over 20 years in staffing and outsourcing experience, much of which has been within the field of clinical research. Previously the President of a mid-sized, global CRO, Steve has witnessed first-hand the staggering number of opportunities drug sponsors have to capitalize on efficiencies and technology to reduce timelines, costs and delays within their workflows. As the CEO of Clinovo, Steve is dedicated to bringing these solutions to the market and breaking through the vicious cycle of inefficiencies that plague the industry.
With an eye for great talent, Steve has cultivated a team of experienced professionals that also value innovation, quality and progress above the status quo, in order to revolutionize the way research outsourcing is done today and in the future.
VP of Business Development
Matt Gallant With 13+ years of expertise, Matt has a strong background in guiding clients through staff augmentation, workforce optimization, and outsourcing strategy. His journey began in healthcare, transitioning eight years ago to focus on Biopharmaceutical sponsors. Being local to the greater Boston area, he's particularly enjoyed his involvement in the Northeast Biopharma community, where he actively collaborates with leaders to solve clinical trial execution challenges and helps foster crucial industry connections.
Through this involvement, he's witnessed firsthand how inefficient trial processes-such as an over-reliance on outdated traditional workforce and outsourcing models, suboptimal resource allocation, and a lack of seamless collaboration with CRO partners-not only inflate costs but also directly impede the rapid advancement of innovative treatments.
Lead Clinical Advisor
Dawn McCollough With over 30 years of experience in the Pharmaceutical, Biotech, and Contract Research Organization (CRO) sectors, Dawn brings a proven track record of success in global clinical trial management across all phases and numerous therapeutic areas.
Her expertise encompasses executive-level business operations, including board participation and chairing, as well as the build-up and oversight of clinical operations groups, quality management, and extensive process development and improvement. She also possesses deep knowledge of clinical trial management systems and has a consistent record of top-tier performance within major pharmaceutical companies.
Chief Technical Officer
Nivedita (Neetha) is a technology executive and multiple- time founder with four successful startup exits. She has a deep technology background and vast experience ranging from Al, network technologies, cyber security to virtual reality.
Her 20+ years of experience span both startups and global enterprises across Silicon Valley and India. Neetha has built engineering organizations from the ground up and delivered product roadmaps from inception through successful market adoption. She holds a Master’s degree in Computer Science from Stanford University.
